Metered Dose Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	53 Pages	GlobalData	July, 2021	GBDT16741731

Best Price Guarantee
Price	from $2,500
Length	53 Pages
Publisher	GlobalData
Published Date	July, 2021
SKU	GBDT16741731

Metered Dose Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021

Summary

GlobalData's Medical Devices sector report, “Metered Dose Inhaler Devices - Medical Devices Pipeline Product Landscape, 2021 provides comprehensive information about the Metered Dose Inhaler Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Metered Dose Inhaler Devices delivers a specific amount of medication to lungs and GI tract. It is mostly used by asthma and COPD patients.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Metered Dose Inhaler Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Metered Dose Inhaler Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Metered Dose Inhaler Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

About GlobalData
Introduction
- Metered Dose Inhaler Devices Overview
Products under Development
- Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  - Table Figure 1: Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
  - Table Metered Dose Inhaler Devices - Pipeline Products by Stage of Development
- Metered Dose Inhaler Devices - Pipeline Products by Territory
  - Table Figure 2: Metered Dose Inhaler Devices - Pipeline Products by Territory
  - Table Metered Dose Inhaler Devices - Pipeline Products by Territory
- Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  - Table Figure 3: Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
  - Table Metered Dose Inhaler Devices - Pipeline Products by Regulatory Path
- Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  - Table Figure 4: Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
  - Table Metered Dose Inhaler Devices - Pipeline Products by Estimated Approval Date
- Metered Dose Inhaler Devices - Ongoing Clinical Trials
  - Table Figure 5: Metered Dose Inhaler Devices - Ongoing Clinical Trials
  - Table Metered Dose Inhaler Devices - Ongoing Clinical Trials
Metered Dose Inhaler Devices - Pipeline Products under Development by Companies
- Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
  - Table Metered Dose Inhaler Devices Companies - Pipeline Products by Stage of Development
- Metered Dose Inhaler Devices - Companies Pipeline Products by Stage of Development
  - Table Metered Dose Inhaler Devices - Companies Pipeline Products by Stage of Development
Metered Dose Inhaler Devices Companies and Product Overview
- Adamis Pharmaceuticals Corp Company Overview
  - Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table APC-1000 Beclomethasone Metered Dose Inhaler - Product Status
    - Table APC-1000 Beclomethasone Metered Dose Inhaler - Product Description
- Aeropharm GmbH Company Overview
  - Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table Aeropharm GmbH Pipeline Products & Ongoing Clinical Trials Overview
    - Table VAL050 pMDI Valve / Actuator - Product Status
    - Table VAL050 pMDI Valve / Actuator - Product Description
- Aerophase Inc Company Overview
  - Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Aerophase Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Aerosol-Delivery System - NTM Respiratory Infection - Product Status
    - Table Aerosol-Delivery System - NTM Respiratory Infection - Product Description
    - Table Metered Dose Inhaler - Product Status
    - Table Metered Dose Inhaler - Product Description
- Bespak Europe Ltd Company Overview
  - Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table Bespak Europe Ltd Pipeline Products & Ongoing Clinical Trials Overview
    - Table VAL020 Metered Dose Inhaler Valve - Product Status
    - Table VAL020 Metered Dose Inhaler Valve - Product Description
- Circassia Group Plc Company Overview
  - Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Circassia Group Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Fluticasone propionate/Salmeterol xinafoate pMDI - Product Status
    - Table Fluticasone propionate/Salmeterol xinafoate pMDI - Product Description
- Globe Medical Tech Inc (Inactive) Company Overview
  - Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
    - Table Inhaler - Product Status
    - Table Inhaler - Product Description
- GoFire Inc Company Overview
  - GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table GoFire Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Gofire Inhaler - Product Status
    - Table Gofire Inhaler - Product Description
- Lab Automate Technologies Inc Company Overview
  - Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Lab Automate Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Ultrasonic Metered Dose Inhaler - Product Status
    - Table Ultrasonic Metered Dose Inhaler - Product Description
- Lupin Pharmaceuticals Inc Company Overview
  - Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Albuterol MDI - Product Status
    - Table Albuterol MDI - Product Description
- Medicom Innovation Partner a/s Company Overview
  - Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
    - Table Medicom Innovation Partner a/s Pipeline Products & Ongoing Clinical Trials Overview
    - Table Asmair - Product Status
    - Table Asmair - Product Description
- Nemera La Verpilliere Company Overview
  - Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
    - Table Nemera La Verpilliere Pipeline Products & Ongoing Clinical Trials Overview
    - Table RetroNose - Product Status
    - Table RetroNose - Product Description
- Pearl Therapeutics Inc Company Overview
  - Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Pearl Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table PT001 - Product Status
    - Table PT001 - Product Description
    - Table PT010 - Product Status
    - Table PT010 - Product Description
- Rapid Therapeutic Science Laboratories Inc Company Overview
  - Rapid Therapeutic Science Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Rapid Therapeutic Science Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Rxoid - Product Status
    - Table Rxoid - Product Description
    - Table Rapid Therapeutic Science Laboratories Inc - Ongoing Clinical Trials Overview
    - Table Rxoid - A Study to Evaluate the Rxoid Metered Dose Inhaler (MDI) Technology to Deliver Cannabinoid Compounds in Patients with Anxiety
- Reciprocal Labs Corp Company Overview
  - Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Reciprocal Labs Corp Pipeline Products & Ongoing Clinical Trials Overview
    - Table Connected Metered Dose Inhaler - Product Status
    - Table Connected Metered Dose Inhaler - Product Description
- Rensselaer Polytechnic Institute Company Overview
  - Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
    - Table Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
    - Table Bloom Inhaler - Product Status
    - Table Bloom Inhaler - Product Description
- TM Global Bioscience LLC Company Overview
  - TM Global Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table TM Global Bioscience LLC Pipeline Products & Ongoing Clinical Trials Overview
    - Table ApelinDx - Product Status
    - Table ApelinDx - Product Description
- Vectura Group Plc Company Overview
  - Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Flutiform pMDI - Product Status
    - Table Flutiform pMDI - Product Description
- Verona Pharma Plc Company Overview
  - Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
    - Table RPL554 - Metered Dose Inhaler - Product Status
    - Table RPL554 - Metered Dose Inhaler - Product Description
    - Table Verona Pharma Plc - Ongoing Clinical Trials Overview
    - Table RPL554 - Metered Dose Inhaler - A Single-center, Pilot, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine in the Recovery of Hospitalized Patients with Covid-19
Metered Dose Inhaler Devices- Recent Developments
- Jul 21, 2021: Novartis Announces Q2 2021 Financial Results
- Jul 08, 2021: H&T Presspart Tarragona open State-Of-The-Art offices
- Jun 08, 2021: Desert Oasis Healthcare, Propeller Health expand partnership to improve outcomes for asthma and COPD patients
- Apr 29, 2021: Merck Announces First-Quarter 2021 Financial Results
- Apr 29, 2021: Viatris to Participate in BofA Securities 2021 Health Care Conference
- Apr 27, 2021: Novartis key growth drivers and launches continue momentum in Q1, maintaining confidence in growth. Group guidance for FY 2021 confirmed
- Apr 12, 2021: Viatris to Release First Quarter 2021 Financial Results on May 10, 2021
- Mar 29, 2021: Merck to Hold First-Quarter 2021 Sales and Earnings Conference Call on April 29
- Mar 22, 2021: Novartis appoints Karen Hale as Chief Legal Officer
- Mar 04, 2021: Viatris to Participate in Barclays Global Healthcare Conference
- Mar 03, 2021: Merck to Present at the Barclays Global Healthcare Conference
- Feb 24, 2021: Merck to Present at the Cowen 41st Annual Health Care Conference
- Feb 11, 2021: Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences
- Feb 05, 2021: Merck CFO Brings Corporate Strategy Experience to CEO Role
- Jan 12, 2021: Vectura Group: Trading update
- Sep 24, 2020: H&T Presspart: Revolutionising Medical Cannabis Drug Delivery Webinar
- Sep 01, 2020: Novartis announces ambitious ESG targets to increase access to medicines and achieve full carbon neutrality
Appendix
- Methodology
  - Table Glossary
- About GlobalData
- Contact Us
- Disclaimer